H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 93 Citations 33,954 404 World Ranking 5239 National Ranking 56

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Diabetes mellitus
  • Gene

Internal medicine, Endocrinology, Type 2 diabetes, Insulin and Insulin resistance are his primary areas of study. Allan Vaag has included themes like Diabetes mellitus, Regulation of gene expression and Gene expression in his Internal medicine study. The concepts of his Diabetes mellitus study are interwoven with issues in Glucose transporter, Heritability, Myocardial infarction and Genetic predisposition.

His work deals with themes such as Epigenetics and DNA methylation, which intersect with Endocrinology. His Type 2 diabetes research includes elements of Metformin, Genome-wide association study, Type 2 Diabetes Mellitus and Glucose homeostasis. In his work, Gastric inhibitory polypeptide is strongly intertwined with Glucagon-like peptide-1, which is a subfield of Insulin.

His most cited work include:

  • Epigenetic differences arise during the lifetime of monozygotic twins (2717 citations)
  • Interleukin-1-receptor antagonist in type 2 diabetes mellitus. (1385 citations)
  • Interleukin-1-receptor antagonist in type 2 diabetes mellitus. (1385 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Internal medicine, Endocrinology, Type 2 diabetes, Insulin and Insulin resistance. His research integrates issues of Diabetes mellitus, Type 2 Diabetes Mellitus and DNA methylation in his study of Internal medicine. His Diabetes mellitus research includes themes of Offspring, Pregnancy and Gestational diabetes.

In his research, Low birth weight and Physiology is intimately related to Birth weight, which falls under the overarching field of Endocrinology. His Type 2 diabetes study integrates concerns from other disciplines, such as Body mass index, Gastroenterology, Randomized controlled trial, Metabolic syndrome and Epigenetics. His research ties Metabolism and Insulin together.

He most often published in these fields:

  • Internal medicine (98.72%)
  • Endocrinology (87.21%)
  • Type 2 diabetes (60.13%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (98.72%)
  • Type 2 diabetes (60.13%)
  • Gestational diabetes (13.86%)

In recent papers he was focusing on the following fields of study:

Allan Vaag mostly deals with Internal medicine, Type 2 diabetes, Gestational diabetes, Insulin resistance and Endocrinology. His works in Body mass index, Insulin, Clinical trial, Odds ratio and Concomitant are all subjects of inquiry into Internal medicine. His Type 2 diabetes research is classified as research in Diabetes mellitus.

His Gestational diabetes research also works with subjects such as

  • Physiology, DNA methylation, Fetus and Obesity most often made with reference to Offspring,
  • Obstetrics which intersects with area such as Quartile and Lower risk,
  • Cohort, which have a strong connection to Epidemiology. His research investigates the connection with Insulin resistance and areas like Epigenetics which intersect with concerns in Adipose tissue, Epigenome and Cell biology. Allan Vaag interconnects Birth weight and Low birth weight in the investigation of issues within Endocrinology.

Between 2016 and 2021, his most popular works were:

  • Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors (129 citations)
  • Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial. (62 citations)
  • Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial. (62 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Diabetes mellitus
  • Gene

Allan Vaag mainly focuses on Internal medicine, Type 2 diabetes, Gestational diabetes, Endocrinology and Offspring. His study in Autophagy extends to Internal medicine with its themes. The Type 2 diabetes study combines topics in areas such as Body mass index, Physical therapy, Birth weight and Cohort study.

His Endocrinology study typically links adjacent topics like DNA methylation. His Offspring research is multidisciplinary, incorporating elements of Diabetes mellitus and Fetus. His study in Diabetes mellitus is interdisciplinary in nature, drawing from both Blood pressure and Cohort.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Epigenetic differences arise during the lifetime of monozygotic twins

Mario F. Fraga;Esteban Ballestar;Maria F. Paz;Santiago Ropero.
Proceedings of the National Academy of Sciences of the United States of America (2005)

3807 Citations

Interleukin-1-receptor antagonist in type 2 diabetes mellitus.

Claus M Larsen;Mirjam Faulenbach;Allan Vaag;Allan Vaag;Aage Vølund.
The New England Journal of Medicine (2007)

1821 Citations

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

D. Russell-Jones;A. Vaag;O. Schmitz;B. K. Sethi.
Diabetologia (2009)

947 Citations

Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance--a population-based twin study.

P. Poulsen;K. Ohm Kyvik;A. Vaag;H. Beck-Nielsen.
Diabetologia (1999)

741 Citations

Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People

Tina Ken Schramm;Gunnar H. Gislason;Lars Køber;Søren Rasmussen.
Circulation (2008)

645 Citations

Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients.

M. A. Gall;P. Rossing;P. Skøtt;P. Damsbo.
Diabetologia (1991)

501 Citations

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.

Tina Ken Schramm;Gunnar Hilmar Gislason;Allan Vaag;Jeppe Nørgaard Rasmussen.
European Heart Journal (2011)

494 Citations

Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia.

Johan Rung;Stéphane Cauchi;Anders Albrechtsen;Lishuang Shen;Lishuang Shen.
Nature Genetics (2009)

482 Citations

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

Bianca Hemmingsen;Søren S Lund;Christian Gluud;Allan Vaag.
Cochrane Database of Systematic Reviews (2015)

475 Citations

Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes

Claus M. Larsen;Mirjam Faulenbach;Allan Vaag;Jan A. Ehses.
Diabetes Care (2009)

414 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Allan Vaag

Leif Groop

Leif Groop

Lund University

Publications: 135

Gunnar H. Gislason

Gunnar H. Gislason

National Heart Foundation of Australia

Publications: 112

Oluf Pedersen

Oluf Pedersen

University of Copenhagen

Publications: 111

Mark I. McCarthy

Mark I. McCarthy

University of Oxford

Publications: 102

Torben Hansen

Torben Hansen

University of Copenhagen

Publications: 100

Jens J. Holst

Jens J. Holst

University of Copenhagen

Publications: 95

Christian Torp-Pedersen

Christian Torp-Pedersen

Aalborg University

Publications: 86

Susan E. Ozanne

Susan E. Ozanne

University of Cambridge

Publications: 82

Henning Beck-Nielsen

Henning Beck-Nielsen

Odense University Hospital

Publications: 77

Johan G. Eriksson

Johan G. Eriksson

University of Helsinki

Publications: 70

David Evans

David Evans

University of Bristol

Publications: 69

Dorret I. Boomsma

Dorret I. Boomsma

Vrije Universiteit Amsterdam

Publications: 68

Philippe Froguel

Philippe Froguel

Imperial College London

Publications: 67

Jaakko Kaprio

Jaakko Kaprio

University of Helsinki

Publications: 67

Lars Køber

Lars Køber

Copenhagen University Hospital

Publications: 66

Something went wrong. Please try again later.